100 Clinical Results associated with Pharos Generics Holding SA
0 Patents (Medical) associated with Pharos Generics Holding SA
On 23.08.2024 the Austrian Federal Competition Authority was notified of the following merger: Planned purchase process Blue Holding GmbH & Co. KG, Germany, which will be jointly held by Armira Blue GmbH & Co geschlossene Investment KG and Viessmann Generations Group GmbH & Co. KG, both Germany, intends to acquire a minority shareholding above 25% and below 50% in Pharos Generics Holding S.A., Greece (with the remaining shares being held by three of the four current shareholders of Pharos Generics Holding S.A.). Economic sector: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 20.09.2024. Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date. Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position. Non-prohibition of the merger The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 21.09.2024.
100 Deals associated with Pharos Generics Holding SA
100 Translational Medicine associated with Pharos Generics Holding SA